summari zimmer biomet report decent result
morn modest revenu beat in-lin
ep first earn call host compani new ceo
bryan hanson despit below-consensu guid y/i
ex-fx adjust one less bill day came away feel
confid ceo renew focu execut long-term
strateg vision zimmer biomet immedi focu
complet qualiti remedi north campu restor
full suppli posit compani acceler growth new
estim lower believ initi
critic posit zimmer biomet long-term success
ep y/i ep
y/i maintain
base ep estim
top line beat higher opex lead in-lin ep revenu
y/i y/i ex-fx came
manag guidanc also beat consensu
estim quarter benefit fx partial
addit sell day ad guidanc
guidanc respect top-lin growth
compani adjust organ growth compar
guidanc flat versu
revers recent quarterli trend
result benefit variou tailwind better-than-
anticip trend recon market aid insur
dynam recoveri hurrican impact growth
acceler asia pacif apac region aid strong
distributor order benefit partial extra sell
day price worsen adjust ldr
spine quarter acquisit fulli integr juli
elsewher gross margin declin y/i in-
line compani expect due continu increment
manufactur inventori cost relat warsaw north campu
facil impact price declin sg margin declin
y/i due lower non-sal forc incent base
compens expens net-net adjust ep y/i
came-lin expect within compani guidanc
rang
continu page
compani data secur llc estim reuter
ep exclud amort non-recur item
compani prioriti stock list
compani data secur llc estim reuter
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
continu previou page
outlook commentari provid manag provid outlook
today call provid full year guidanc provid next earn call
expect low-point year sequenti improv throughout guidanc
also assum sequenti deceler global orthoped market versu elev level
compani look revenu y/i ex-fx adjust one less sell
day adj ep new estim respect
factor consid respect guidanc includ tailwind fx
benefit full year headwind sell day differ expect
even full year suppli level north campu expect least match
level push elect procedur februari end due capac constraint
announc nation health servic elsewher manag expect gross margin
y/i low-end effect tax rate
y/i latter fulli off-set plan sg invest higher pay bonu
compens compani intend use cash flow gener pay debt expect
cash flow first quarter year
global recon market growth like acceler big four recon hip knee
implant compani report result base result estim
global recon market growth like acceler sequenti y/i led
sequenti acceler y/i global hip acceler sequenti y/i
led acceler unit state global knee acceler sequenti
y/i driven estim acceler unit state manag note
expect enhanc season versu level quarter end stronger
initi expect estim hip market deliv growth closer
 knee market deliv closer line model color follow
earn commentari smith nephew snn schedul report
close open latter like materi alter market given rel
modest share recon market roughli
segment result top-lin growth driven continu momentum set surgic sport medicin
foot ankl extrem trauma asia pacif region result stack follow
knee y/i ex-fx zimmer report knee revenu versu
repres ex-fx growth versu quarter result driven declin
apac america off-set growth europ middl east africa
emea overal price knee declin versu off-set
growth volume/mix versu manag note call segment
benefit stronger market uptak persona partial knee system howev
note growth gap zimmer market like widen quarter like due
increas competit headwind unit state dissimilar heard
johnson johnson come surpris us recal pre-announc
robust growth knee aid strong uptak total knee applic tka
mako platform look ahead believ zimmer may abl mitig headwind
on-going global launch fix bear persona uni-compartment knee roll mid
replac zbh divest zuk fix bear knee launch persona revis knee
revis total knee market launch persona cementless knee
report knee mix versu remov suppli bottleneck remain
critic turnaround full launch rosa tka import zimmer
get offens
hip y/i ex-fx zimmer report hip revenu versu
repres growth versu apac post growth complement
growth america off-set emea declin overal price hip declin
versu off-set somewhat growth volume/mix versu
result aid uptick procedur volum off-set suppli headwind high-
set sale y/i ex-fx zimmer report set revenu versu
repres growth versu price set declin versu
somewhat off-set growth volume/mix versu growth set led
sever product categori includ surgic shoulder within upper extrem
off-set continu suppli issu look ahead believ result aid roll
sidu stemless shoulder system address estim stemless segment
spine cmf sale y/i ex-fx zimmer report spine cmf revenu
versu repres growth versu price segment declin
versu almost off-set growth volume/mix versu
cmf thorac post strong growth led strong product demand spine segment
neg impact salesforc integr dis-synergi recent senior leadership chang
off-set demand mobi-c cervic disc
dental sale y/i ex-fx zimmer report dental revenu versu
repres growth versu price dental declin versu
off-set growth volume/mix versu revenu
exceed compani intern target aid growth america apac off-set
disrupt europ due busi realign
sale y/i ex-fx zimmer report revenu versu
repres growth versu price segment declin versu
off-set somewhat growth volume/mix versu
suppli level track in-lin north campu arent expect deterior
encourag note suppli level north campu facil target expect
least in-lin sequenti improv anticip ahead meaning
impli intern initi gain traction zimmer struggl manufactur suppli
headwind recent quarter produc inconsist yield handicap abil
improv growth gain market share said ceo note risk associ
timelin restor full suppli simpli given complex task
specif delay point note compani note chang product launch timelin
ceo bryan hanson discuss maintain parallel-path contract manufactur move
manufactur locat ireland part long-term strategi gross margin
remain pressur improv sequenti suppli level recov yield becom
consist north campu gener increment product cost expect
sourc leverag begin
new updat remedi effort new updat fda visit standpoint
compani continu gain input consult look invest qualiti manag
system remedi cost increment expect note
fda visit key mileston zimmer first inspect
typic timelin month long
strateg vision includ prioriti ceo bryan hanson note first step ceo would
posit zimmer competit market current oper posit compani
revenu growth acceler achiev would establish effect qualiti control bring
suppli back normal level make sale forc invest least improv
commerci execut acknowledg revenu acceler may lag even suppli fulli
restor salesforc re-establish trust senior manag manag believ
may posit get offens gain share full knee
portfolio includ rosa tka furthermor on-going focu establish driven cultur
focu bring higher standard disciplin rigor organ
price target nc
price target base cash ep estim risk thesi includ
increas invest slower procedur volum growth price pressur disrupt
integr biomet
zimmer biomet share trade approxim discount large-cap med-tech peer
group believ discount narrow next twelv month compani benefit
leadership new commercially-driven ceo bryan hanson oper issu resolv
 pipelin begin fulli appreci
warsaw indiana-bas zimmer biomet hold one world largest orthoped implant
manufactur compani global market leader billion reconstruct orthoped
implant busi hip knee implant togeth account roughli revenu
compani report sale billion
